Skip to main content


Details of the Drug
Generic Name:
Drug Type:
Selective T cell co-stimulation modulator
How the Drug is Given:

Injection, for intravenous use; Injection, for subcutaneous use


Indications and Usage

Abatacept is a indicated for the prophylaxis (prevention) of acute graft versus host disease (aGVHD), in combination with a calcineurin inhibitor and methotrexate, in adults and pediatric patients 2 years of age and older undergoing hematopoietic stem cell transplantation (HSCT) from a matched or 1 allele-mismatched unrelated donor. 

Side effects needing medical attention

Most common adverse events are anemia, hypertension, CMV reactivation/CMV infection, fever, pneumonia, nose bleeds, CD4 lymphocytes decreased, hypermagnesemia, and acute kidney injury.

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.